Comorbidity and the Treatment of Principal Anxiety Disorders in a Naturalistic Sample

被引:25
|
作者
Davis, Lissa [1 ]
Barlow, David H. [1 ]
Smith, Lisa [1 ]
机构
[1] Boston Univ, Dept Psychol, Boston, MA 02215 USA
关键词
COGNITIVE-BEHAVIORAL THERAPY; PANIC DISORDER; MAJOR DEPRESSION; CLASSIFICATION; IMPAIRMENT; PREDICTORS; DIAGNOSES;
D O I
10.1016/j.beth.2009.09.002
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study examined the impact of comorbidity on treatment outcome and the effects of cognitive behavioral therapy (CBT) for anxiety and depressive disorders on comorbid disorders in a naturalistic sample of 150 patients presenting to an anxiety disorders clinic. The following results were observed across principal (i.e., most severe) diagnoses. Patients with comorbid anxiety and depressive disorders presented for treatment with higher severity of their principal disorder than patients without comorbidity. However, the presence of comorbidity did not predict dropout or poor treatment response, and patients demonstrated significant improvement in their principal disorders regardless of comorbidity. The frequency of clinically severe and subclinical (i.e., not severe enough to meet diagnostic criteria) comorbid conditions decreased significantly over the course of treatment. The implication of these findings for the classification and treatment of emotional disorders is discussed.
引用
收藏
页码:296 / 305
页数:10
相关论文
共 50 条
  • [21] Impact of anxiety comorbidity on the features and treatment response of bipolar disorders
    Henry, C
    Van den Bulke, D
    Roy, I
    Bellivier, F
    Leboyer, M
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 114 - 114
  • [22] The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
    Freeman, MP
    Freeman, SA
    McElroy, SL
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 1 - 23
  • [23] COMORBIDITY OF ANXIETY DISORDERS IN A MULTICENTER ANXIETY STUDY
    GOISMAN, RM
    GOLDENBERG, I
    VASILE, RG
    KELLER, MB
    COMPREHENSIVE PSYCHIATRY, 1995, 36 (04) : 303 - 311
  • [24] Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors
    Hermanns, N
    Kulzer, B
    Krichbaum, M
    Kubiak, T
    Haak, T
    DIABETIC MEDICINE, 2005, 22 (03) : 293 - 300
  • [25] Hypochondriasis, Somatoform Disorders, and Anxiety Disorders Sociodemographic Variables, General Psychopathology, and Naturalistic Treatment Effects
    Gropalis, Maria
    Bleichhardt, Gaby
    Witthoeft, Michael
    Hiller, Wolfgang
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2012, 200 (05) : 406 - 412
  • [26] Influence of Comorbidity in Cognitive-Behavioral Treatment of Anxiety and Mood Disorders
    Philippe, Jessica
    Provencher, Martin D.
    Belleville, Genevieve
    Busque, Guillaume Foldes
    SANTE MENTALE AU QUEBEC, 2022, 47 (01): : 309 - 331
  • [27] A meta-analysis of the influence of comorbidity on treatment outcome in the anxiety disorders
    Olatunji, Bunmi O.
    Cisler, Josh M.
    Tolin, David F.
    CLINICAL PSYCHOLOGY REVIEW, 2010, 30 (06) : 642 - 654
  • [28] COMORBIDITY AMONG ANXIETY DISORDERS - IMPLICATIONS FOR TREATMENT AND DSM-IV
    BROWN, TA
    BARLOW, DH
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1992, 60 (06) : 835 - 844
  • [29] Understanding the neurobiology of comorbidity in anxiety disorders
    Nutt, David J.
    Stein, Dan J.
    CNS SPECTRUMS, 2006, 11 (10) : 13 - 20
  • [30] COST OF ANXIETY DISORDERS - IMPACT OF COMORBIDITY
    SOUETRE, E
    LOZET, H
    CIMAROSTI, I
    MARTIN, P
    CHIGNON, JM
    ADES, J
    TIGNOL, J
    DARCOURT, G
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1994, 38 : 151 - 160